Drug Type Small molecule drug |
Synonyms INCB-177054, INCB177054 |
Target |
Action inhibitors |
Mechanism DGKA inhibitors(diacylglycerol kinase alpha inhibitors), DGKζ inhibitors(diacylglycerol kinase zeta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 2 | United States | 07 Jul 2025 | |
Metastatic Solid Tumor | Phase 2 | United States | 07 Jul 2025 |